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Spontaneous Eye Blinking, a Measure
of Dopaminergic Function, in Children
With Acquired Immunodeficiency Syndrome
Hestien Vreugdenhil, MA; Pim Brouwers, PhD; Pamela Wolters, PhD; Dirk Bakker, PhD; Howard Moss, PhD
Objective: To investigate possible alterations in dopa-
minergic function in children with acquired immuno-
deficiency syndrome by evaluating spontaneous eye
blink rate, a putative measure of central dopaminergic
function.
Design: Evaluation of previously videotaped test ses-
sions of a consecutive case series of 50 children (mean
age, 5.2 years; range, 2-12 years) with acquired immu-
nodeficiency syndrome.
Setting: Government medical research center.
Results: Intrarater reliability was high, expected co-
variation of blink rate with age and concurrent mental
activity were confirmed, and obtained rates were simi-
lar to published data. Higher blink rates, suggestive of
increased dopaminergic function, were associated with
more severe cortical atrophy (P<.05) and white matter
abnormality (P<.05) on computed tomographic brain
scans. The presence or severity of basal ganglia calcifi-
cations did not seem to influence blink rate. In addi-
tion, higher blink rates were associated with higher
ratings of depressed affect (P<.05) and lower ratings
of hyperactive behaviors (P<.05) during other test
activities.
Conclusions: The higher blink rates in human immu-
nodeficiency virus\p=n-\infected children with more severe
cortical abnormalities suggest increased central dopa-
mine activity compared with that in children without cor-
tical computed tomographic brain scan abnormalities.
Thus, as a result of structural brain abnormalities, neu-
rotransmitter levels in children with acquired immuno-
deficiency syndrome may vary and this may be reflected
in their socioemotional functioning.
Arch Pediatr Adolesc Med. 1997;151:1025-1032
Editor's Note: Some readers might wonder why we'd publish this
blinking study in the Archives. Actually we're enthusiastic about
mind-brain studies, especially of this caliber.
Catherine D. DeAngelis, MD
IN CHILDREN with symptomatichuman immunodeficiency virustype 1 (HIV-1) infection, cogni¬tive, motor, socioemotional, andbehavioral impairments have
been frequently observed.1"3 These neu-
rodevelopmental deficits have been re¬
lated to central nervous system (CNS) ab¬
normalities.4 The predominant cause of the
CNS abnormalities seems to be related to
the effects of HIV infection of the CNS be¬
cause opportunistic infections and lym-
phoma of the CNS are uncommon in chil¬
dren. Evidence of HIV infection has been
detected in microglia and macrophages
within the CNS, but neurons seem to re¬
main largely uninfected; neurologic dam-
age is postulated to be caused by the re¬
lease of various neurotoxic viral or host
factors.5,6
Based on structural, behavioral, and
biochemical observations, 1 of the conse¬
quences of HIV infection of the CNS could
well be the deregulation of the central, ni-
grostriatal, dopaminergic system. Mag¬
netic resonance imaging, computed to-
mographic (CT) brain scan studies, and
autopsy findings have demonstrated a high
incidence of subcortical neuropathologic
changes, such as basal ganglia mineraliza¬
tions (Figure 1), and other structural
brain abnormalities in children with
HIV infection.712 The neurobehavioral pro¬
file of children with symptomatic HIV
disease is also suggestive of subcortical
abnormalities. Among others, psychomo-
tor slowing,1 relative weakness of expres¬
sive compared with receptive language,13
and lack of facial expressiveness14—all
have been observed in children with HIV
infection. Similar profiles of neurocogni-
tive dysfunctioning in adults with HIV
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SUBJECTS AND METHODS
SUBJECTS
Patients seen at the Pédiatrie Branch of the National Can¬
cer Institute, Bethesda, Md, as participants in phase 1 and
2 clinical trials of antiretroviral agents3233 were eligible for
participation in this study. These protocols were ap¬
proved by the National Cancer Institute's Institutional Re¬
view Board, and written consent was obtained from the par¬
ent or legal guardian of each child. As part of comprehensive
medical monitoring, patients were evaluated based on CT
brain scan findings, age-appropriate neuropsychological test
results, which included a videotape procedure,14 and CD4
count analysis prior to or shortly after (<1 week) starting
an antiretroviral treatment protocol. These tests were re¬
peated after 6 months of antiretroviral treatment. Most (66%)
of the children previously had been following other anti¬
retroviral treatment protocols with zidovudine or dideoxy-
inosine or both, but they were eligible for a new protocol
because of disease progression or toxic effects. At the time
of the neurobehavioral evaluation, children were afebrile
and were not suffering from another infection. Between April
1989 and March 1994, 112 pédiatrie patients with symp¬
tomatic HIV disease were videotaped.
Because the objective of this study was to evaluate the
association between HIV-associated CNS abnormalities and
behavior, 1 child with Down syndrome, who also had a nys¬
tagmus, was excluded from the analysis because of cogni¬
tive and neurological abnormalities unrelated to HIV-1 in¬
fection.
Children younger than 2 years (n = 45) were
excluded from this study because previous studies had
demonstrated that spontaneous blinking in infants and
young children is rare and irregular.2630 One subject
who was 19.1 years old was also excluded because he
was 7 years older than the second oldest subject in the
sample. The videotapes of 15 subjects were not évalu¬
able according to the criteria described below because
the quality of the videotape was poor (the child was
positioned badly, or the room was too dark [n=13] or
because the eyes of the children were not observable
long enough as they were too active [n=2]). Thus, the
videotapes of 50 children were considered évaluable.
The mean (±SD) age of these children was 5.2±0.4
years (Table). Most (37 of 50) children acquired HIV-1
by a vertical route of infection. Mean parental education,
defined as the average years of education of either the
father or the mother, was 13.4 years. The encephalo-
pathic (n = 27) and nonencephalopathic group (n = 23)
did not differ in age (mean [±SEM] age, 5.0±0.6 years
vs 5.3±0.7 years), sex distribution (56% male vs 74%
male), route of HIV infection (81% vs 65% vertically
acquired infection) or mean (±SEM) level of parental
education (13.4±0.5 years vs 13.3±0.5 years).
PROCEDURES
Videotape Evaluation
Children were videotaped for 20 to 30 minutes while
engaged in many age-appropriate tasks that were
designed to elicit task-oriented, interpersonal-social,
sensorimotor, and communicative behaviors, as well as
affect.14 The videotaping procedure has been adminis¬
tered since 1989, at first to all consecutive patients but
since July 1, 1992, only to children with evidence of
encephalopathy and/or to those younger than 3 years,
because of time constraints.
For this study, a videotape was considered évaluable
if it contained at least 3 minutes, during which the eyes of
the child could be observed and external stimuli, possibly
causing blinks, were minimal. The total period for the de¬
termination of the blink rate could be obtained by adding
several epochs of a minimal length of 1 minute. Ifmore than
1 évaluable videotape was available for a subject, the ear¬
liest one was used.
Every videotape was first evaluated to identify, record,
and classify epochs that satisfied the above-mentioned
criteria. A record was created, which identified the begin¬
ning and the end of the epochs; online timing of the epochs
was accomplished using the VCR timer. The activity, if it
lasted at least 1 minute, was noted. Three distinct mental
activities were identified: conversation, listening, and fine-
motor performance. If the subject was involved in more than
1 activity during an epoch, that activity was classified as
mixed activity.
For each videotape, the record that indicated the
beginning and end and the concurrent mental activity
for each epoch was copied. The videotapes were then
viewed for a second time, and the first copy of the
record was used to guide and record the counting of the
eye blinks. After evaluating all videotapes, they were
viewed for a third time and a blank copy of the record
was used to record the second counting of the eye
blinks.
I_
have been interpreted as reflecting subcortical demen¬
tia15 and basal ganglia disease.16
Biochemical evidence for decreased activity of the
central dopaminergic system has come from adult
patients, especially those with acquired immunodefi¬
ciency syndrome (AIDS) dementia complex. Some
studies1718 have reported lower concentrations of
dopamine or its metabolite homovanillic acid in the
cerebrospinal fluid of patients with AIDS. Further¬
more, lower levels were related to lower CD4 lympho¬
cyte counts and to the presence of neurologic and cog¬
nitive or motor deficits.
A recent report15 has shown improvement in
motor function with levodopa therapy in a small
sample of HIV-infected children with extrapyramidal
syndromes, which may suggest abnormal dopaminer-
gic function. Central dopaminergic function, however,
has not been studied directly or indirectly. A putative
and noninvasive method to evaluate central dopamin¬
ergic activity that involves both D[ and D2 dopamine
receptors is through the spontaneous eye blink rate.20
This approach has been validated in neurochemical
studies with humans21 and across different species22-23
and in studies of patients with known dopaminergic
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Neuropsychological Evaluation
The general level of cognitive functioning was assessed with
age-appropriate standardized tests. A general index of men¬
tal abilities (GIMA) was defined as the Full-Scale Intelli¬
gence Quotient of the Wechsler Intelligence Scale for Chil¬
dren-Revised,34 which was administered to patients aged
6 through 16 years (n=22); the General Cognitive Index
of the McCarthy Scales of Children's Abilities,'5 which was
administered to children aged 30 months through 6 years(n=14); and the Mental Developmental Index of the Bay-
ley Scales of Infant Development,36 which was adminis¬
tered to infants aged 2 to 30 months (n=14). For children
and infants who scored below the deviation scale cutoff on
the Bayley and McCarthy Scales (n=4), ratio IQs were cal¬
culated as described elsewhere,32 based on the age equiva¬
lent for the obtained raw score on the test and the child's
chronological age. All GIMA scores less than 40 were set
to 39 for equivalence and computational purposes.37
Socioemotional Behavior
The psychologist administering the cognitive tests also
rated the child's socioemotional behavior during the psy¬
chometric evaluation using the National Institutes of
Health Q-sort behavior rating procedure38 (n=41). This
is a forced-choice rating procedure resulting in item
scores between 1 and 7. Scaled scores are calculated
based on an average equal-weight computation of items
loading on derived factors from a factor analysis. The
Q-sort procedure generates 4 scales, which reflect the
following behaviors: depression, hyperactivity or atten¬
tion deficit, autism, and low frustration and/or irritabil¬
ity threshold.
Neuroimaging Evaluations
For 46 of the 50 children, a CT brain scan was available; it
was obtained within 4 months of the videotape proce¬
dure. These scans were rated using a previously de¬
scribed, highly reliable semiquantitative technique.8 Briefly,
2 neurologists, blind to the clinical status of the patients,
independently rated the CT scans for the presence and se¬
verity of ventricular dilatation, subarachnoid enlarge¬
ment, white matter abnormalities, intracerebral calcifica¬
tions, and possible other lesions on 100-mm analog scales.
In addition, an overall rating was given, which served as a
composite for all observed abnormal findings. The aver¬
age of the raters' scores was used.
Immunological Evaluation
The CD4% was determined as an indicator of stage of HIV
disease. Because of rapid physiological changes in normal
CD4 levels in the first 4 years of life, a formula was used to
transform the data to age-adjusted standard (z) scores.39,40
We used CD4% rather than absolute CD4 values because
its variability is significantly smaller41 and the age-
adjustment is more uniform,39 which makes it a more re¬
liable measure and better suited for our current study. The
CD4 counts within a week from the date of the videotapes
were available for 48 of the subjects.
HIV-ENCEPHALOPATHY CLASSIFICATION
Children were classified as encephalopathic or nonen-
cephalopathic, based on the following nonmutually exclu¬
sive criteria, which have been used consistently in our pro¬
gram32,33 (because of the lack of a generally accepted
classification for HIV-associated encephalopathy of child¬
hood,4243 we recognize that these criteria may differ in other
institutions): (1) evidence of neurocognitive deteriora¬
tion (loss of skills or milestones) in functioning (n=9), (2)
general level of functioning more than 2 SDs below norm(GIMA, <70; n=19), and (3) general level of functioning
between 1 and 2 SDs below the norm and evidence of mod¬
erate to severe CNS abnormality on CT brain scan (score,
>49 on the analog rating for overall severity of abnormal¬
ity8; n=6). Patients who did not fulfill any of these 3 cri¬
teria were classified as nonencephalopathic (n=23).
DATA ANALYSIS
Blink rates (in bpm) were calculated for each of the classified
cognitive activities (conversation, listening, and fine motor)
and an overall blink rate for each videotape. A square root trans¬
formation was standardly applied, because the data were posi¬
tively skewed, which normalized the scores. We back-
transformed the data when presenting them in tables and graphs.
Intraclass reliabilities44 between the first and second
counting were computed. As the intrarater reliabilities were
appropriate (see the "Results" section), the average of the
2 counts was used in all subsequent analyses.
As noted before, because the blink rate is age depen¬
dent, analysis of covariance and partial correlation were used
for adjusting for age effects. Additionally, data were ana¬
lyzed with the t test analysis of variance, Fisher exact test,
and Pearson correlation. A minimal 2-tailed a level of .05
was used in all analyses.
dysfunction such as Parkinson disease24"26 and schizo¬
phrenia.2027 Lower blink rates are associated with
decreased activity of the central dopaminergic system.
Cortical control of the spontaneous eye blink rate is
evidenced by its modulation with concurrent mental ac¬
tivity. The blink rate is significantly reduced during visu¬
ally demanding tasks2628 or during tasks requiring concen¬
tration and mental activity,29 and it is significantly increased
during casual conversation28 compared with blink rates dur¬
ing rest conditions. Blink rates remain constant when sub¬jects are involved in a single activity.26 Developmentally,
blink rates increase significantly from an irregular and very
low rate of 0.7 blinks per minute (bpm) in infants to a rate
of about 17 bpm by age 20 years, when it remains rela¬
tively constant.30 The effect of concurrent mental activity
on the blink rate is similar for children and adults.31
In this study, the spontaneous eye blink rates in chil¬
dren with symptomatic HIV disease, which were obtained
from videotaped behavior samples, were evaluated. Our pur¬
pose was to ascertain whether lower age-adjusted blink rates
were associated with the following: presence of encepha-
lopathy, greater severity ofbrain imaging abnormalities, and
more advanced status of HIV disease, as reflected by lower
age-adjusted CD4 percentage (CD4%) values.
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Figure 1. Computed tompgraphic brain scan of a 4.5-year-old patient with
vertically acquired human immunodeficiency virus infection and classified as
encephalopathic. Severity of the bilateral calcifications in the basal ganglia
was rated in the mild-to-moderate range. Cortical atrophy, reflected by both
enlargement of the subarachnold spaces and dilatation of the ventricles, was
rated in the moderate-to-severe range.
RESULTS
GENERAL SAMPLE DESCRIPTION
Psychometric Data
The general level of cognitive functioning for this
sample of pédiatrie HIV-infected patients (mean[±SEM] GIMA, 77.7±3.5) was more than 1 SD below
the published norm (100). The mean [±SEM] GIMA of
the encephalopathic group (60.0±2.8) was signifi¬
cantly lower (P<.001) than that of the nonencephalo-
pathic children (98.5±3.5).
In the socioemotional domain, encephalopathic chil¬
dren exhibited significantly more depressive (mean[±SEM] score, 3.6±0.3 vs 2.8±0.2; P<.05) and autis¬
tic (mean [±SEM] score, 2.6 + 0.2 vs 1.5±0.1; P<.001)
behaviors compared with the nonencephalopathic chil¬
dren on the Q-sort rating procedure. Differences on the
hyperactivity or attention deficit (P>.50) and irritabil¬
ity or low frustration threshold (P>.20) scales were not
significant. The mean levels on these 4 scales were com¬
parable to earlier reported levels for these HIV sub¬
groups.38
The GIMA score correlated significantly with
the autism rating (R=-0.60; P<.001), but with none
of the other 3 scales of the socioemotional behavior
rating.
Characteristics of the Children With Symptomatic Human
Immunodeficiency Virus Infection
GroupAll
Characteristics Children Encephalopathic Nonencephalopathic
Sex, M/F ratio 32/18 15/12 17/6
Route of infection 37/13 22/5 15/8
vertical/
transfusion ratio
Age, y* 5.15±3.0 5.04+2.9 5.29±3.2
Parental 13.4 13.4 13.3
education, y
GIMA*f 77.7±24.8 60.0±14.7 98.5±16.7
Calcifications 13 12 1
present, No.
CD4%, zscores** -3.27±1.5 -4.03±0.9 -2.37±1.6
* Data are mean±SD.
tGIMA indicates general index of mental abilities (defined in the
"Neuropsychological Evaluation" subsection of the "Procedures "section in
"Subjects and Methods").
XAge-corrected z scores for CD4 lymphocyte subset percentages (CD4%).
Neuroimaging (CT Scan) Findings
Almost all children (98%) in this sample were rated as
having at least 1 abnormal finding on the CT brain scan.
For more than half the subjects, the CNS abnormalities
were rated as minimal or mild (32% and 24%, respec¬
tively). For 35% of the children, the CNS abnormalities
were rated as moderate; for 9% of the children, as se¬
vere. The most frequently seen lesion was cortical atro¬
phy (ventricular dilatation or subarachnoid enlarge¬
ment or both8). Thirteen subjects (28%) had calcifications
in the basal ganglia or in the frontal white matter or in
both sites. As has been noted previously,8 these lesions
were more common (P<.01) in vertically infected (12[32%] of 37) compared with transfusion-infected chil¬
dren (1 [8%] of 13). The overall severity rating of the CT
brain scan abnormalities in the encephalopathic group(mean [±SEM], 56.5±13.4) was significantly higher(P<.001) than in the nonencephalopathic group (mean[±SEM],22.6±3.6).
Computed tomographic brain scan abnormalities,
particularly cortical atrophy, were related with a lower
GIMA (R=-0.59; P<.001) and higher abnormality
ratings on the depression (R=0.51; P<.005) and the
autism (R = 0.51; P<.005) scales of the Q-sort
procedure.
Immunologie Findings
The overall age-adjusted level of CD4% was signifi¬
cantly below the reported level39 of non-HIV-infected
children (z=— 3.27±0.22). As expected, the level of
immune depletion for the encephalopathic children(z=-4.03±0.17) was significantly greater (P<.001)
than for the nonencephalopathic children(z=-2.37±0.35)
Similarly, age-adjusted CD4% correlated with over¬
all CT brain scan abnormality (R= -0.54; P<.001), par¬
ticularly cortical atrophy (R= —0.53), and with the level
of cognitive functioning (R=0.45; P<.005).
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Fine Motor Conversation
Concurrent Mental Activity
Listening
Figure 2. Relation between mean blink rates (in blinks per minute [bpm])
and concurrent mental activity in children with symptomatic human
immunodeficiency virus disease. Significantly higher blink rates were seen
during conversation (P<.01) and listening (P<.05) compared with those
during a fine-motor task. The difference between conversation and listening
was not significant (P>.40).
- I
Minimal Mild Moderate Severe
Degree of CT Brain Scan Abnormality
Figure 3. Comparison of mean blink rates (in blinks per minute ¡bpm]) in
children with symptomatic human immunodeficiency virus disease,
classified as having a minimal (analog rating, 0-24; n=15), mild (analog
rating, 25-49; n* 11), moderate (analog rating, 50-74; n= 16), or severe(analog rating, 75-100; n=4) degree of computed tomographic (CT) brain
scan abnormality (Ft =0.37; P<.05).
RELIABILITY AND VALIDITY
Intrarater Reliability
Intrarater reliability was highly significant for both the
overall blink rate and its square root transformation(R=0.99). Similarly, significant reliability coefficients were
found for the blink rate during conversation (n=15;
R=0.97), listening (n=13; R=0.98), and fine-motor per¬
formance (n=31; R=0.997).
Effect of Concurrent Mental Activity on Blink Rate
There were significant differences among the mean blink
rates during conversation, listening, and fine-motor per¬
formance (F= 14.39; P<.001) (Figure 2). These statis¬
tics should be considered with some caution, because com¬
plete data about all 3 conditions were only available for 8
subjects. Post hoc pairwise comparisons demonstrated that
blink rates were significantly lower during fine-motor tasks
compared with those during conversation (n= 12; F=21.64;
P<.001) and listening (n-11; F=7.73; P<.02). The dif¬
ference between blink rates during listening and conver¬
sation (n=9; F=0.71; P>.50) was not significant.
The overall blink rate correlated significantly with
the blink rates for the 3 activities: fine-motor perfor¬
mance (R=0.67; P-C001), conversation (R=0.88; P<.001),
and listening (R=0.59; P<.04). Thus, the use of an over¬
all blink rate was justified as a composite measure.
CORRELATIONS WITH BLINK RATE
CT Brain Scan Variables
Greater severity ofoverall CT brain scan abnormalities were
significantly associated with higher age-adjusted blink rates(partial correlation coefficient, 0.37; P<.05) (Figure 3).
When evaluating the different CT brain scan abnormalities
that make up the overall CT rating, severity of cortical at¬
rophy (R=0.37; P<.05), and ofwhite matter abnormalities
(R=0.35;P<.05), but not severity ofcalcifications (R=0.15;
P>.30), were significantly related to higher blink rates.
In addition, blink rates of children with calcifica¬
tions (n= 13) and without calcifications (n=33) were com¬
pared. Because children with calcifications had signifi¬
cantly (P<.02) higher severity of cortical atrophy (mean[±SEM] rating, 50.2±5.8) compared with that of chil¬
dren without calcifications (mean [±SEM] rating,
29.9±4.4), analysis of covariance was used to adjust for
cortical atrophy and age. The adjusted mean (±SEM)
blink rates of the 2 groups were almost identical(4.50±0.53vs4.49±0.81).
Disease and Demographic Variables
Relations between blink rate and sex or route of infec¬
tion were not significant. There was a nonsignificant trend
for higher blink rates to be associated with lower age-
adjusted CD4% values (R=~0.25; P=.10).
Psychological Variables
Blink rate was not significantly related to the GIMA(R=—0.22; P=.14). Significant relations, however,
were found with the behavior rating measures for the
depression (R=0.32; P<.05) and the hyperactivity or
attention deficit (R=-0.32; P<.05) scales.
SUBGROUP DIFFERENCES IN BLINK RATES:
ENCEPHALOPATHY
The difference in age-adjusted blink rates between en¬
cephalopathic and nonencephalopathic children(4.85±0.60 bpm vs 3.85±0.62 bpm) was not statisti¬
cally significant (P=.25).
COMMENT
Spontaneous eye blink frequency was used in this study
as a putative measure to evaluate central dopaminergic
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activity in children with symptomatic HIV infection. Ab¬
normalities of the dopaminergic system were hypoth¬
esized because a subset of children with HIV infection
have a profile of neurobehavioral deficits suggestive of
subcortical abnormalities, and approximately one third
of the children with vertically acquired infection have neu-
ropathologic changes in the basal ganglia.8 Moreover, de¬
creased cerebrospinal fluid levels of dopamine or its me¬
tabolite homovanillic acid have been reported in adult
patients with AIDS and were related to the severity of neu¬
rologic deficits.1718 In addition, improvements in motor
functioning with fevodopa therapy have been reported
in HIV-infected children with extrapyramidal syn¬
dromes.19 Therefore, decreased blink rates could be ex¬
pected in children with more advanced HIV-associated
neurological disease, especially in patients with calcifi¬
cations in the basal ganglia.
OUR RESULTS, however, do not seem tosupport these hypotheses. Higher blinkrates, which have been associated withincreased central dopaminergic activ¬ity, were related to greater severity of CT
brain scan abnormalities, particularly with more severe
cortical atrophy and white matter abnormality. Blink rates
of children with basal ganglia calcifications were no dif¬
ferent from those of children without calcifications. There
was a nonsignificant trend for blink rates to be higher,
rather than lower, in children with HIV-associated en-
cephalopathy compared with nonencephalopathic pa¬
tients.
The method used in the current study to measure
the spontaneous blink rate seems to be valid and reli¬
able. The intrarater intraclass reliabilities were accept¬
able. Moreover, our data replicated a number of com¬
mon characteristics of the blink rate seen in normal
children and adults. Concurrent mental activity signifi¬
cantly modulated spontaneous eye blink rates in a way
similar to that in normal children and adults.2831 First,
blink rates were significantly elevated during conversa¬
tion and listening compared with those during fine-
motor tasks. Second, the mean blink rates in the current
study were comparable to previously published rates in
normal children30 and showed a comparable increase with
age (for children between 1-5 years of age, 3.4 bpm in
normal children vs 3.8±0.4 bpm in our study; for chil¬
dren between 5-10 years of age, 6.1 bpm in normal chil¬
dren vs 5.6±0.9 bpm in our study).
Further validation of our procedure is provided by
the relation that we obtained between blink rates and de¬
pression. Blink rate correlated significantly with the de¬
pression ratings from the Q-sort procedure,38 particu¬
larly with such items as "seems sad" and "doesn't smile
or laugh." Increased blink rates also have been reported
for adult patients with depression45 and depressive af¬
fective disorder.46
In general, brain imaging abnormalities and en-
cephalopathy in pédiatrie patients with AIDS have been
related to cognitive dysfunctioning and aberrant socio-
emotional behavior patterns. An exception were hyper¬
active behaviors that have been associated with the ab-
sence of encephalopathy,38 less severe cortical atrophy,4
and more intact immune function.47 In non-HIV-
infected children, hyperactivity has been related to lower
levels of dopamine.48'49 A recent study50 also reported lower
blink rates for children with attention deficit hyperac¬
tivity disorder who were not receiving stimulant medi¬
cation compared with those for normal children. These
findings support the data from the current study that
higher ratings on the hyperactivity or attention deficit
scale of the Q-sort behavior rating procedure (particu¬
larly on items such as "is excitable and impulsive") were
related to lower blink rates. However, HIV-infected chil¬
dren with hyperactive behaviors may only be a small sub¬
group. In a recent retrospective study of 116 children with
symptomatic HIV disease (H.M., unpublished data, Janu¬
ary 8, 1997), we found that the prevalence of significant
hyperactive behaviors, defined as scoring more than 2
SDs above the norm on the Conners' Rating Scales,51 was
only 10%.
Spontaneous blink rates are partially controlled by
a neural system with inhibitory modulation from the cer¬
ebellum and occipital cortex.52 Increased blink rates may
signify the disinhibition of this neural system.53 After le¬
sions of the cerebellum or cerebellectomy in children53
and animals,34 increased spontaneous blink rates have
been demonstrated. Furthermore, blinks are sup¬
pressed during visual and electrical activity in the visual
cortex.55 Moreover, after lesions in the prefrontal cor¬
tex, an increase in subcortical dopamine level has been
demonstrated in rats.56 The structural cortical abnor¬
malities in our patients, therefore, may cause a down-
regulation of the cortical inhibitory system52 and an up-
regulation of the dopaminergic system of the basal ganglia,
resulting in an increase in spontaneous blinking. Stud¬
ies in schizophrenic patients, who are hypothesized to
have chronically high dopaminergic function,57 tend to
support this interpretation. Schizophrenic patients with
enlarged ventricles seemed to respond less to treatment
with neuroleptic drugs (dopamine antagonists) than did
comparable patients without enlarged ventricles.58 Ad¬
ditionally, the increased blink rates in schizophrenic pa¬
tients with enlarged ventricles were not decreased by neu¬
roleptic therapy, whereas the blink rate in those patients
with normal ventricles did decrease with similar doses
of neuroleptic drugs.27
There is not much insight yet how basal ganglia cal¬
cifications in pédiatrie HIV disease affect the function¬
ing of the basal ganglia. A recent functional brain imag¬
ing study in 8 vertically infected children reported basal
ganglia hypermetabolism in children with basal ganglia
calcification.59 Hypermetabolism in the basal ganglia has
also been reported for adults, in whom basal ganglia cal¬
cifications were absent, in the early, but not late, stages
of AIDS dementia complex.60 Similarly, our findings do
not suggest a reduction in dopaminergic activity, as mea¬
sured by blink rate, in children with basal ganglia calci¬
fications compared with children without calcifica¬
tions.
Despite significant correlations of cortical atrophy
with blink rate and with general level of cognitive abili¬
ties, the correlation between blink rate and general level
of cognitive abilities did not reach statistical signifi-
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canee. This suggests that the blink rate may reflect other
aspects of CNS function affected by HIV disease than those
measured by tests of general cognitive function. Previ¬
ous studies2 38 have demonstrated that socioemotional be¬
haviors also may be compromised by HIV-1-associated
CNS disease in children. The significant correlations of
blink rate with hyperactivity or attention deficit and de¬
pression ratings suggest that blink rates may be more re¬
flective of the socioemotional domain.
The findings of our study, suggesting increased do¬
paminergic function in children with more severe CNS
abnormalities, seem at variance with the adult HIV stud¬
ies17"18 and the pédiatrie AIDS treatment study19 that sug¬
gested decreased dopaminergic function. One reason for
these differences could be that the stage of (CNS) HIV
infection itself may have a direct influence on neuro-
transmitter levels. Animal studies61 have shown that CNS
infections may raise central dopamine levels, particu¬
larly in the acute phase. Furthermore, in vitro studies have
shown that increased production of noradrenaline, an as¬
sociated neurotransmitter, is related to higher levels of
HIV-1 viral products, such as gp-120, in a human neu¬
ral brain cell line.62
It is possible that, in our study, the more acute HIV
infection, including the CNS, may have led to compar¬
atively higher dopamine levels than are those in the pa¬
tients in the other studies. Most children in our study
either had not been treated with antiviral drugs before
or showed progressive disease while receiving an anti¬
viral protocol at the time of enrollment to the study.32"33
We have previously shown that HIV-1 provirus is de¬
tected more often at autopsy in both the cerebrum and
cerebellum of children than of adults with AIDS and at
higher viral burden, as shown with the use of polymer-
ase chain reaction.63-64
Further studies direcdy measuring dopamine or its me¬
tabolite hemovanillic acid level in the cerebrospinal fluid
of children with symptomatic HIV disease are necessary to
support the findings and conclusions of this study. How¬
ever, unbiased collection of cerebrospinal fluid samples from
infants and children is difficult. Administering lumbar punc¬
tures and spinal taps to children in general requires a clini¬
cal justification, and that very clinical event may influ¬
ence the levels of the compound under study.
In summary, this study demonstrated increased spon¬
taneous blink rates in HIV-positive children, with more
severe degrees of CT brain scan abnormality, particu¬
larly cortical atrophy and white matter lesions. Because
spontaneous blink rates are a putative measure of cen¬
tral dopaminergic activity, these findings suggest in¬
creased dopaminergic activity in this subgroup of chil¬
dren with symptomatic HIV disease.
Accepted for publication June 25, 1997.
A preliminary portion of this study was presented at
the 19th Annual Mid-Year Meeting of the International Neu-
ropsychological Society, fune 20,1996, Veldhoven, the Neth¬
erlands. The abstract was published as Vreugdenhil H, Moss
H, Wolters P, Bakker D, Brouwers P. Evaluation of spon¬
taneous eye blinking as a putative measure of central do¬
paminergicfunction in children with symptomatic HIV-1 in¬
fection. J Int Neuropsychol Soc. 1996;2:190. Abstract.
We express our appreciationfor the time and effort given
by the children and their caregivers who participated in this
research. We also thank Charles DeCarlí, MD, and Lucy
Civitello, MD, for their evaluation of the CT brain scans,
and Phdip Pizzo, MD, Eugene Tassone, Renee Smith, MA,
Debra El-Amin, MA, Nancy Heilman, PhD, and Gayl Selkin-
Gutman, MA, for their assistance during the various phases
of this project.
Reprints: Pirn Brouwers, PhD, Pédiatrie Neuropsy-
chology Group, National Cancer Institute, National Insti¬
tutes ofHealth Bldg 10, Room 13N240, Bethesda, MD 20892-
1928 (e-mail: pb56u@nih.gov).
REFERENCES
1. Aylward EH, Butz AM, Hutton N, Joyner ML, Vogelhut JW. Cognitive and motor
development in infants at risk for human immunodeficiency virus. AJDC. 1992;
146:218-222.
2. Belman AL, Brouwers P, Moss H. HIV-1 and the central nervous system. In: Kauf-
man DM, Solomon GE, Pfeffer CR, eds. Child andAdolescent Neurology forPsy-
chiatrists. Baltimore, Md: Williams & Wilkins; 1992:238-253.
3. Epstein LG, Sharer LR, Oleske JM, et al. Neurologic manifestations of human
immunodeficiency virus infection in children. Pediatrics. 1986;78:678-687.
4. Brouwers P, DeCarli C, Civitello LA, Moss H, Wolters P, Pizzo P. Correlation be-
tween computed tomographic brain scan abnormalities and neuropsychologi-
cal function in children with symptomatic human immunodeficiency virus dis-
ease. Arch Neurol. 1995;52:39-44.
5. Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection
of the nervous system: pathogenic mechanisms. Ann Neurol. 1993;33:429\x=req-\
436.
6. Lipton SA. HIV-related neuronal injury: potential therapeutic intervention with cal-
cium channel antagonists and NMDA antagonists. Mol Neurobiol. 1994;8:181\x=req-\
196.
7. Chamberlain MC, Nichols SL, Chase CH. Pediatric AIDS: comparative cranial MRI
and CT scans. Pediatr Neurol. 1991;7:357-362.
8. DeCarli C, Civitello LA, Brouwers P, Pizzo PA. The prevalence of computed axial
tomographic abnormalities of the cerebrum in 100 consecutive children symp-
tomatic with the human immunodeficiency virus. Ann Neurol. 1993;34:198\x=req-\
205.
9. Kauffman WM, Sivit CJ, Fitz CR, Rakusan TA, Herzog K, Chandra RS. CT and
MR evaluation of intracranial involvement in pediatric HIV infection: a clinical\x=req-\
imaging correlation. Am J Neuroradiol. 1992;13:949-957.
10. Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection
of the nervous system. Hum Pathol. 1991;22:700-710.
11. Price DB, Inglese CM, Jacobs J, et al. Pediatric AIDS: neuroradiologic and neu-
rodevelopmental findings. Pediatr Radiol. 1988;18:445-448.
12. Wiley CA, Belman AL, Dickson DW, Rubinstein A, Nelson JA. Human immuno-
deficiency virus within the brains of children with AIDS. Clin Neuropathol. 1990;
9:1-6.
13. Wolters PL, Brouwers P, Moss HA, Pizzo PA. Differential receptive and expres-
sive language functioning of children with symptomatic HIV disease and rela-
tion to CT scan brain abnormalities. Pediatrics. 1995;95:112-119.
14. Moss HA, Wolters PL, Brouwers P, Hendricks ML, Pizzo PA. Impairment of ex-
pressive behavior in pediatric HIV-positive patients with evidence of CNS dis-
ease. J Pediatr Psychol. 1996;21:379-400.
15. Brouwers P, Mohr E, Hildebrand K, et al. A novel approach to the determination
and characterization of HIV dementia. Can J Neurol Sci. 1996;23:104-109.
16. Martin A. HIV, cognition, and the basal ganglia. In: Grant I, Martin A, eds. Neu-
ropsychology of HIV Infection. New York, NY: Oxford University Press; 1994:
234-259.
17. Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B. Cerebrospinal fluid do-
pamine in HIV-1 infection. AIDS. 1994;8:67-71.
18. Larsson M, Hagberg L, Forsman A, Norkrans G. Cerebrospinal fluid catechol-
amine metabolites in HIV-infected patients. J Neurosci Res. 1991;28:406-409.
19. Mintz M, Tardieu M, Hoyt L, McSherry G, Mendelson J, Oleske J. Levodopa therapy
improves motor function in HIV-infected children with extrapyramidal syn-
dromes. Neurology. 1996;47:1583-1585.
20. Karson CN. Spontaneous eye-blink rates and dopaminergic systems. Brain. 1983;
106:643-653.
21. Blin O, Masson G, Azulay JP, Fondaray J, Serratice G. Apomorphine-induced blink-
ing and yawning in healthy volunteers. BrJ Clin Pharmacol. 1990;30:769-773.
 at Vrije Universiteit, on November 24, 2010 www.archpediatrics.comDownloaded from 
22. Karson CN, Staub RA, Kleinman JE, Wyatt RJ. Drug effect on blink rates in rhe-
sus monkeys: preliminary studies. Biol Psychiatry. 1981;16:249-254.
23. Elsworth JD, Lawrence MS, Roth RH, et al. D1 and D2 dopamine receptors inde-
pendently regulate spontaneous blink rate in vervet monkey. J Pharmacol Exp
Ther. 1991;259:595-600.
24. Hall A. The origin and purposes of blinking. Br J Ophthalmol. 1945;89:507-516.
25. Karson CN, Burns S, LeWitt PA, Foster NL, Newman RP. Blink rates and disor-
ders of movements. Neurology. 1984;34:677-678.
26. Ponder E, Kennedy WP. On the act of blinking. Quart J Exp Physiol. 1927;18:
89-119.
27. Kleinman JE, Karson CN, Weinberger DR, Freed WJ, Berman KF, Wyatt RJ. Eye\x=req-\
blinking and cerebral ventricle size in chronic schizophrenic patients. Am J Psy-
chiatry. 1984;141:1430-1432.
28. Karson CN, Berman KF, Donnelly EF, Mendelson WB, Kleinman JE, Wyatt RJ.
Speaking, thinking, and blinking. PsychiatrRes. 1981;5:243-246.
29. Telford CW, Thompson N. Some factors influencing voluntary and reflex eyelid
responses. J Exp Psychol. 1933;16:524-539.
30. Zametkin AJ, Stevens JR, Pittman R. Ontogeny of spontaneous blinking and of
distribution of the reflex blink. Ann Neurol. 1979;5:453-457.
31. Caplan R, Guthrie D. Blink rate in childhood schizophrenia spectrum disorder.
Biol Psychiatry. 1994;35:228-234.
32. Brouwers P, Moss H, Wolters P, et al. Effect of continuous infusion zidovudine
therapy on neuropsychologic functioning in children with symptomatic human
immunodeficiency virus infection. J Pediatr. 1990;117:980-985.
33. Butler KM, Husson RN, Balis FM, et al. Dideoxyinosine (ddl) in symptomatic HIV\x=req-\
infected children: a phase I-IIstudy. N Engl J Med. 1991;324:137-144.
34. Wechsler D. Manual for the Wechsler Intelligence Scale for Children. New York,
NY: Psychological Corp; 1974.
35. McCarthy D. Scales of Children's Abilities. New York, NY: Psychological Corp;
1972.
36. Bayley N. Manual for theBayley Scales of Infant Development. San Antonio, Tex:
Psychological Corp; 1969.
37. Brouwers P, Belman A, Epstein L. Central nervous system involvement: mani-
festations and evaluation. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The Chal-
lenge of HIV Infection in Infants, Children, and Adolescents. Baltimore, Md: Willi-
ams & Wilkins; 1991:318-335.
38. Moss HA, Brouwers P, Wolters PL, Wiener L, Hersh SP, Pizzo PA. The develop-
ment of a Q-sort behavior rating procedure for pediatric HIV patients. J Pediatr
Psychol. 1994;19:27-46.
39. European Collaborative Study. Age-related standards for T lymphocyte subsets
based on uninfected children born to human immunodeficiency virus\p=n-\infected
women. Pediatr Infect Dis J. 1992;11:1018-1026.
40. Brouwers P, Tudor-Williams G, DeCarli C, et al. Relation between stage of dis-
ease and neurobehavioral measures in children with symptomatic HIV disease.
AIDS. 1995;9:713-720.
41. Raszka WV, Meyer GA, Waecker NJ, et al. Variability of serial absolute and per-
cent CD4+ lymphocyte counts in healthy children born to human immunodefi-
ciency virus 1\p=n-\infected parents. Pediatr Infect Dis J. 1994;13:70-72.
42. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW. Human
immunodeficiency virus (HIV) infection and the nervous system: report from
the American Academy of Neurology AIDS Task Force. Neurology. 1989;39:
119-122.
43. Belman AL. Acquired immunodeficiency syndrome and the child's central ner-
vous system. Pediatr Clin North Am. 1992;39:691-714.
44. Bartko JJ, Carpenter WT. On the methods and theory of reliability. J Nerv Ment
Dis. 1976;163:307-317.
45. Mackintosh JH, Kumar R, Kitamura T. Blink rate in psychiatric illness. Br J Psy-
chiatry. 1983;143:55-57.
46. Depue RA, Iacono WG, Muir R, Arbisi P. Effect of phototherapy on spontaneous
eye blink rate in subjects with seasonal affective disorder. Am J Psychiatry. 1988;
145:1457-1459.
47. Brouwers P, van der Vlugt H, Moss H, Wolters P, Pizzo P. White matter changes
on CT brain scan are associated with neurobehavioral dysfunction in children
with symptomatic HIV disease. Child Neuropsychol. 1995;1:93-105.
48. Levy F. The dopamine theory of attention deficit hyperactivity disorder (ADHD).
Austr N ZJPsychiatry. 1991;25:277-283.
49. McCracken JT. A two-part model of stimulant action on attention-defict
hyperactivity disorder in children. JNeuropsychiatry Clin Neurosci. 1991;3:201\x=req-\
209.
50. Caplan R, Guthrie D, Komo S. Blink rate in children with attention-deficit hyper-
activity disorder. Biol Psychiatry. 1996;39:1032-1038.
51. Conners CK. Connors' Rating Scales, Manual. North Tonawanda, NY: Multi\x=req-\
Health Systems Inc; 1990.
52. Karson CN. Blinking. Bull Soc Beige Ophtalmol. 1989;237:443-457.
53. Karson CN, Dykman RA, Paige SR. Blink rates in schizophrenia. Schizophr Bull.
1990;16:345-354.
54. Freed WJ, Karson CN, Kleinman JE, Wyatt RJ. Increased spontaneous eye\x=req-\
blinks in cerebellectomized rats. BiolPsychiatry. 1981;16:789-792.
55. Volkmann FC, Riggs LA, Moore RK. Eyeblinks and visual suppression. Science.
1980;207:900-902.
56. Pycock CJ, Kerwin RW, Carter CJ. Effect of lesion of cortical dopamine termi-
nals on subcortical dopamine receptors in rats. Nature. 1980;286:74-77.
57. Meltzer HY. Biochemical studies in schizophrenia. In: Bellak L, ed. Disorders of
the Schizophrenic Syndrome. New York, NY: Basic Books; 1979:45-135.
58. Weinberger DR, Biggelow LB. Kleinman JE. Cerebral ventricular enlargement in
chronic schizophrenia: association with poor response to treatment. Arch Gen
Psychiatry. 1980;37:619-623.
59. Depas G, Chiron C, Tardieu M, et al. Functional brain imaging in HIV-1 infected
children born to seropositive mothers. J Nucl Med. 1995;36:2169-2174.
60. Rottenberg DA, Moeller JR, Strocher SC, et al. The metabolic pathology of the
AIDS dementia complex. Ann Neurol. 1987;22:700-706.
61. Lycke E. Roos BE. The monoamine metabolism in viral encephalitides of the mouse.
Brain Res. 1972;44:603-613.
62. Pittaluga A, Pattarini R, Severi P, Raiteri M. Human brain N-methyl-D-aspartate
receptors regulating noradrenaline release are positively modulated by HIV-1 coat
protein gp 120. AIDS. 1996;10:463-468.
63. Sei S, Kleiner DE, Kopp JB, et al. Quantitative analysis of viral burden in tissues
from adults and children with symptomatic human immunodeficiency virus type
1 infection assessed by polymerase chain reaction. JInfect Dis. 1994;170:325\x=req-\
333.
64. Sei S, Saito K, Stewart SK, et al. Increased HIV-1 DNA content and quinolinic
acid concentration in brain tissues obtained from AIDS patients with HIV en-
cephalopathy. J Infect Dis. 1995;172:638-647.
 at Vrije Universiteit, on November 24, 2010 www.archpediatrics.comDownloaded from 
